Fairfax Financial Stock Fair Value Calculation – Prem Watsa’s Fairfax Financial Holdings to Double India Investment to USD 14 Billion by 2023.

March 18, 2023

Trending News 🌥️

This sizable investment is aimed at furthering the economic growth of India by providing capital to businesses and entrepreneurs. The current investment is part of their long-term plans to increase their presence in India. Watsa believes that this investment will create jobs and revenue, while also promoting collaboration and trade between India and other countries. He also commented that the company will continue to look for new opportunities in India and other countries, in order to further bolster their global presence.

Overall, the announcement of Fairfax Financial ($TSX:FFH) Holdings’ plan to double their investment in India over the next 4-5 years is a positive development for the country’s economic growth. Prem Watsa’s dedication to investing in the region is commendable, and this commitment is sure to bring many more business opportunities and prosperity in the years to come.

Price History

Despite this, media sentiment remains predominantly negative, likely due to the company’s stock performance on Monday. On Monday, Fairfax Financial Holdings opened at CA$898.5 and closed at CA$880.9, a decrease of 2.7% from the previous closing price of 905.0. This indicates a downturn in investor confidence in the company, even with the announcement. Live Quote…

About the Company

  • Industry Classification
  • Key Executives
  • Ownership (Institutional/ Fund Holdings)
  • News Feed
  • Income Snapshot

    Below shows the total revenue, net income and net margin for Fairfax Financial. More…

    Total Revenues Net Income Net Margin
    25.82k 1.1k 0.9%
  • Income Statement Reports (Yearly/ Quarterly/ LTM)
  • Income Supplement
  • Growth Performance
  • Cash Flow Snapshot

    Below shows the cash from operations, investing and financing for Fairfax Financial. More…

    Operations Investing Financing
    -4.42k 384.8 -1.29k
  • Cash Flow Statement (Yearly/ Quarterly/ LTM)
  • Cash Flow Supplement
  • Balance Sheet Snapshot

    Below shows the total assets, liabilities and book value per share for Fairfax Financial. More…

    Total Assets Total Liabilities Book Value Per Share
    92.13k 71.79k 691.25
  • Balance Sheet (Yearly/ Quarterly)
  • Balance Sheet Supplement
  • Key Ratios Snapshot

    Some of the financial key ratios for Fairfax Financial are shown below. More…

    3Y Rev Growth 3Y Operating Profit Growth Operating Margin
    6.8% 8.4%
    FCF Margin ROE ROA
    -18.7% 8.6% 1.5%
  • Income Statement Ratios
  • Balance Sheet Ratios
  • Cash Flow Ratios
  • Valuation Ratios
  • Other Ratios
  • Other Supplementary Items
  • Analysis – Fairfax Financial Stock Fair Value Calculation

    After a thorough analysis of FAIRFAX FINANCIAL‘s fundamentals, GoodWhale has concluded that its intrinsic value is around CA$569.3. This value has been calculated using our proprietary Valuation Line. Currently, FAIRFAX FINANCIAL stock is trading at CA$880.9, which is overvalued by 54.7%. We would therefore advise investors to exercise caution when considering investing in this stock. More…

  • Risk Rating Analysis
  • Star Chart Analysis
  • Valuation Analysis
  • Peers

    The Company’s segments include Insurance, Reinsurance, Run-off and Other. The Insurance segment consists of property and casualty insurance companies that operate within the United States, Canada and Bermuda. The Reinsurance segment includes property and casualty reinsurance companies that operate within the United States, Canada and Bermuda. The Run-off segment includes the management of the Company’s runoff businesses. The Other segment includes the Company’s investment management and corporate operations.

    – Argo Group International Holdings Ltd ($NYSE:ARGO)

    Argo Group International Holdings Ltd is a Bermuda-based holding company engaged in the underwriting and sale of property and casualty insurance and reinsurance products in the United States, Bermuda, Latin America and selected other international markets. The Company’s segments include Excess and Surplus Lines, Commercial Specialty, International Specialty, Syndicate 1200 and Argo Ventures. It offers a range of products, including general liability, commercial automobile liability, workers’ compensation, professional liability, excess liability, property, surety and marine coverages.

    – Axis Capital Holdings Ltd ($NYSE:AXS)

    Axis Capital Holdings Ltd is a Bermuda-based holding company engaged in the business of providing risk management solutions. The Company’s segments include Insurance, which provides primary casualty, property, professional lines, agricultural and other insurance products; Reinsurance, which provides reinsurance products and services; and Investment Management, which manages the Company’s investments. As of December 31, 2016, the Company had assets of $9.0 billion and shareholders’ equity of $4.6 billion.

    – Hagerty Inc ($NYSE:HGTY)

    Hagerty Inc is a specialty insurance company that focuses on providing coverage for collector and vintage vehicles. The company has a market cap of 746.19M as of 2022 and a Return on Equity of -41.52%. Hagerty was founded in 1984 and is headquartered in Traverse City, Michigan.

    Summary

    Currently, media sentiment towards the company is mostly negative. When deciding whether to invest in Fairfax Financial, investors should consider factors such as the financial health of the company, the management’s long-term vision for growth and expansion, and any current or future risks that may arise. Analysts should also consider the current economic climate and any potential risks associated with investing in the Indian market.

    Additionally, investors should keep an eye on any changes in the company’s key performance indicators, such as its return on assets, debt-to-equity ratio, and cash flow. Overall, Fairfax Financial is a good investment opportunity for those who have faith in its management and the Indian market.

    Recent Posts

    Leave a Comment